Symposium on Myeloid Neoplasms

June 9, 2012
University of Rochester, Eastman School of Music
433 Main Street, Hatch Recital Hall, Rochester, New York
7:30 AM 5:00 PM
Reception 5:30 PM 6:30 PM

In honor of Dr. John M. Bennetts 80th year and his dedication to leukemia research and
community volunteerism for the Arts: to benefit the James P. Wilmot Cancer Center and the
Rochester Philharmonic Orchestra. Dr. Bennett was the first Clinical Director of the University of
Rochester Cancer Center and the founder and chairman of the MDS Foundation. He has served as editorin-chief of the journal Leukemia Research for 20 years, chair of the Scientific Advisory Board of BioReference Laboratories for 10 years, and a member of the board of directors of Rochester Philharmonic
Orchestra. He is professor emeritus and is serving as an attending hematopathologist in the
Hematopathology Section of the Department of Pathology at the University of Rochester. He has
authored and/or co-authored over 500 publications. He received the award for Career Achievement in
Clinical Hematology in 2003 from the Celgene Corporation, and the BJ Kennedy Award for Scientific
Excellence in Geriatric Oncology from ASCO in 2011. Dr. Bennett earned his B.A. from Harvard University
and his M.D. from Boston University.
To register: contact Phoebe Downing at leukemiaresearch@urmc.rochester.edu or call 585-275-4915.
There is no cost to attend this all day event. Breakfast and lunch will be provided, with a reception to
follow. Space is still available...pre-registration by May 15 is highly appreciated.
Whether or not you are able to join in the celebration, please consider a donation in Dr.
Bennetts honor to benefit the James P. Wilmot Cancer Center and the Rochester Philharmonic
Orchestra. Gifts can be made by contacting Phoebe at the email above. All donors will, unless otherwise
requested, be acknowledged in a commemorative format on a gift for Dr. Bennett.
Event

Program Presenters:
David Peter Coppen, ESM, Rochester, NY History of the RPO and Eastman School of Music
Craig Jordan PhD, URMC, Rochester, NY The Leukemia Stem Cell
David Steensma MD, Harvard University, Boston, MA MDS: Historical Perspective
James Vardiman MD, University of Chicago, Chicago, IL Diagnosis of MDS: From FAB to WHO
and Beyond
Torsten Haferlach MD, MLL, Munich, Germany Molecular Genetics in MDS
Charlotte Niemeyer MD, Universitats-Kinderklinik, Freiberg, Germany JMML: Molecular and
Therapeutic Aspects
Ulrich Germing MD, Heinrich-Heine University, Dusseldorf, Germany MDS: Prognostic Scores
Jonathan Friedberg MD, URMC, Rochester, NY Therapy related MDS/AML-What is the
Cost/Benefit Ratio
Pierre Fenaux MD, Hospital Avicenne, Bobigny, France Therapy of MDS-Focus on Higher Risk
Patients
Alan List MD, Moffitt Cancer Center, Tampa, FL New agents in MDS
Jane Liesveld MD, URMC, Rochester, NY Management of AML: Who do we really cure?
Ayalew Tefferi MD, Mayo Clinic, Rochester, MN Myeloproliferative Neoplasms-New Approach
Gordon Phillips MD, URMC, Rochester, NY Allogeneic HSC Transplant for the high-risk patient

Sponsored by: University of Rochester Dept. of Pathology & Laboratory Medicine, Division of
Hematology/Oncology, and The Clinical & Translational Science Institute